Is overexpression of CD163 and CD47 in tumour cells of breast carcinoma implicated in the recruitment of tumour-associated macrophages (TAMs) in tumour microenvironment? immunohistochemical prognostic study.

Q2 Health Professions
Marwa Mohammed Dawoud, Hayam Abd El Samie Aiad, Norhan Safwat Kasem, Enas Abu-Bakr El Khouly, Dalia Rifaat Al-Sharaky
{"title":"Is overexpression of CD163 and CD47 in tumour cells of breast carcinoma implicated in the recruitment of tumour-associated macrophages (TAMs) in tumour microenvironment? immunohistochemical prognostic study.","authors":"Marwa Mohammed Dawoud, Hayam Abd El Samie Aiad, Norhan Safwat Kasem, Enas Abu-Bakr El Khouly, Dalia Rifaat Al-Sharaky","doi":"10.1080/15321819.2024.2358879","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Now, targeted therapy and immunotherapy are promoted. tumour -Associated Macrophages (TAMs) are an essential component of immune-response in breast cancer(BC) with prognostic controversy. Additionally, their recruiting factors are still obscure. Purpose:This study aimed to evaluate the prognostic significance of CD163 and CD47 in BC of No Special Type (BC-NST) and to explore their suggested role in recruiting TAMs.</p><p><strong>Material and methods: </strong>This immunohistochemical study was conducted on 91 archival specimens of breast cases. Immunoreactivity scores were correlated with TAMs density, clinicopathological data, and survival.</p><p><strong>Results: </strong>Revealed the highest CD163 expression was detected in the pure DCIS group (<i>p</i> = 0.016), while the highest CD47 expression and high TAMs density were reported in the invasive group (<i>p</i> = 0.008, and <i>p</i> = 0.002 respectively) followed by the DCIS group. In IC-NSTs the CD163 and CD47 scores were associated with poor prognostic parameters like(high grade, advanced stage, distant metastasis, ER negativity,Ki67 index, post-surgical chemotherapy, poor NPI group, high mitotic count, dense infiltration of TAMs, shorter OS). Also, CD47 was associated with the dens infiltration of TAMs in DCIS (<i>p</i> = 0.001). There was a significant correlation between tumour cell expression of CD163 and CD47 in IC-NSTs and DCIS (<i>p</i> = 0.002 and <i>p</i> = 0.009 respectively).</p><p><strong>Conclusions: </strong>High CD163 and CD47 expressions in both DCIS andIBC are intimately associated, significantly associated with poor prognosis and are important provoking factors of TAMs.</p>","PeriodicalId":15990,"journal":{"name":"Journal of immunoassay & immunochemistry","volume":" ","pages":"342-361"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of immunoassay & immunochemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/15321819.2024.2358879","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/30 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Health Professions","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Now, targeted therapy and immunotherapy are promoted. tumour -Associated Macrophages (TAMs) are an essential component of immune-response in breast cancer(BC) with prognostic controversy. Additionally, their recruiting factors are still obscure. Purpose:This study aimed to evaluate the prognostic significance of CD163 and CD47 in BC of No Special Type (BC-NST) and to explore their suggested role in recruiting TAMs.

Material and methods: This immunohistochemical study was conducted on 91 archival specimens of breast cases. Immunoreactivity scores were correlated with TAMs density, clinicopathological data, and survival.

Results: Revealed the highest CD163 expression was detected in the pure DCIS group (p = 0.016), while the highest CD47 expression and high TAMs density were reported in the invasive group (p = 0.008, and p = 0.002 respectively) followed by the DCIS group. In IC-NSTs the CD163 and CD47 scores were associated with poor prognostic parameters like(high grade, advanced stage, distant metastasis, ER negativity,Ki67 index, post-surgical chemotherapy, poor NPI group, high mitotic count, dense infiltration of TAMs, shorter OS). Also, CD47 was associated with the dens infiltration of TAMs in DCIS (p = 0.001). There was a significant correlation between tumour cell expression of CD163 and CD47 in IC-NSTs and DCIS (p = 0.002 and p = 0.009 respectively).

Conclusions: High CD163 and CD47 expressions in both DCIS andIBC are intimately associated, significantly associated with poor prognosis and are important provoking factors of TAMs.

乳腺癌肿瘤细胞中 CD163 和 CD47 的过度表达是否与肿瘤微环境中肿瘤相关巨噬细胞(TAMs)的招募有关?
背景:肿瘤相关巨噬细胞(TAMs)是乳腺癌(BC)免疫反应的重要组成部分,其预后存在争议。此外,其招募因素仍不明确。目的:本研究旨在评估CD163和CD47在无特殊类型乳腺癌(BC-NST)中的预后意义,并探讨它们在招募TAMs中的作用:这项免疫组化研究是在91例乳腺病例的档案标本上进行的。免疫反应评分与TAMs密度、临床病理数据和存活率相关:结果显示:纯DCIS组的CD163表达量最高(p = 0.016),而浸润组的CD47表达量和TAMs密度最高(分别为p = 0.008和p = 0.002),其次是DCIS组。在 IC-NSTs 中,CD163 和 CD47 评分与不良预后参数相关,如(高级别、晚期、远处转移、ER 阴性、Ki67 指数、手术后化疗、不良 NPI 组、高有丝分裂计数、TAMs 密集浸润、较短的 OS)。此外,CD47与DCIS中TAMs的密集浸润有关(p = 0.001)。在IC-NSTs和DCIS中,肿瘤细胞表达CD163和CD47之间存在明显的相关性(分别为p = 0.002和p = 0.009):结论:CD163和CD47在DCIS和IBC中的高表达密切相关,与不良预后显著相关,是TAMs的重要诱发因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.50
自引率
0.00%
发文量
38
审稿时长
>12 weeks
期刊介绍: The Journal of Immunoassay & Immunochemistry is an international forum for rapid dissemination of research results and methodologies dealing with all aspects of immunoassay and immunochemistry, as well as selected aspects of immunology. They include receptor assay, enzyme-linked immunosorbent assay (ELISA) in all of its embodiments, ligand-based assays, biological markers of ligand-receptor interaction, in vivo and in vitro diagnostic reagents and techniques, diagnosis of AIDS, point-of-care testing, clinical immunology, antibody isolation and purification, and others.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信